Cepheid (NASDAQ: CPHD) reported Q4 EPS of $0.07, may not compare to the analyst estimate of ($0.20). Revenue for the quarter came in at $147 million versus the consensus estimate of $146.91 million.

GUIDANCE:

Cepheid sees FY2016 EPS of $0.22-$0.28, may not compare to the consensus of ($0.48). Cepheid sees FY2016 revenue of $618-635 million, versus the consensus of $622.43 million.

For earnings history and earnings-related data on Cepheid (CPHD) click here.